Voice disorder study: can botox help patients get back to work?

NCT ID NCT06561334

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how spasmodic dysphonia, a voice disorder causing uncontrollable vocal cord spasms, affects patients' jobs and social lives. Researchers will interview 20 adults who have received at least one botulinum toxin injection to understand if the treatment helps improve their livelihood. The goal is to gather insights, not to test a new therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
botulinum toxin injections
What this could lead to
If successful, this study could highlight how botulinum toxin injections improve the social and economic lives of people with spasmodic dysphonia.
What could go wrong
This is a small, early-stage observational study with only 20 participants, so findings may not apply to all patients. It does not test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for QUALITY OF LIFE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Manchester University NHS Foundation Trust

    Manchester, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.